| our studies for the first time establish p100 as a key tumor suppressor of bladder cancer growth | bladder, |
| our studies for the first time establish p100 as a key tumor suppressor of bladder cancer growth | bladder, |
| NF-kappa B2 p100 has I kappa B-independent apoptotic activity and a unique tumour suppressor role | None |
| B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. | lymphoma, |
| Interleukin-1 increases expression of the LYT-10 (NFkappaB2) proto-oncogene/transcription factor in renal cell carcinoma lines. | kidney, |
| Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10. | None |
| The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies. | None |